Healthcare & Life Sciences
Exogenus Therapeutics
Portugalexogenustherapeutics.com
Exogenus Therapeutics is a Healthcare & Life Sciences startup based in Portugal, most recent round Seed, 1 tracked investor.
Activeseed
seed
Stage
1
Investors
About Exogenus Therapeutics
Exogenus Therapeutics is a company headquartered in Portugal. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Exogenus Therapeutics develops exosome-based therapeutics derived from umbilical cord blood cells, targeting tissue regeneration and inflammatory diseases through their lead candidate Exo-101, which has demonstrated regenerative and immunomodulatory properties in preclinical studies.
Explore Exogenus Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.